MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Modulation of executive motor network after neurofeedback training in Parkinson’s disease

    N. Smulders, D. Mehler, L. Subramanian, D. Linden, J. Whittaker (Cardiff, United Kingdom)

    Objective: To identify changes in effective (i.e. directed) connectivity in the executive motor network during finger tapping. To compare the effects of two rehabilitation strategies. …
  • 2017 International Congress

    Volume analysis and localization of midbrain hyperechogenecities via TCS and MRI

    A. Plate, S.-A. Ahmadi, K. Boetzel (Munich, Germany)

    Objective: We are presenting follow-up results on our previous study for 3D volumetric measurements of SN hyper-echogenicities, to differentiate PD patients from healthy controls (HC).…
  • 2017 International Congress

    Integration of risk factors for PD in two large longitudinal cohorts

    I. Kim, E. O'Reilly, K. Hughes, X. Gao, M. Schwarzschild, A. Ascherio (Boston, MA, USA)

    Objective: To derive a risk score for Parkinson’s disease (PD) based on lifestyle factors and family history and assess potential multiplicative and additive interaction between…
  • 2017 International Congress

    “Essential tremor” as a presenting symptom of neuronal intranuclear inclusion disease (NIID).

    Z. Xu, W.-Y. Yu, J. Tan, H.-Y. Lee, Q. Cheng, T. Lim (Singapore, Singapore)

    Objective: To describe a patient with late onset, sporadic NIID who had a tremor as his first complaint. Background: NIID is a rare, slowly progressive…
  • 2017 International Congress

    Tremor-Dominant Clinical Phenotype is Associated with Low Risk of Levodopa-Induced Dyskinesia in Parkinson’s Disease

    B. Santos-Lobato, M. Capelari, N. Novaretti, Â. Vieira, V. Borges, H. Ferraz, I. Mata, C. Zabetian, V. Tumas (Ribeirão Preto, Brazil)

    Objective:  To evaluate possible associations between epidemiological and clinical data with risk of levodopa-induced dyskinesias (LID) onset in  Parkinson’s disease (PD) patients. Background: LID are…
  • 2017 International Congress

    Examining the brain reserve hypothesis in Parkinson’s disease

    P.C. Lee, F. Artaud, F. Cormier, O. Rascol, F. Durif, P. Derkinderen, F. Bourdain, J.-P. Brandel, F. Pico, L. Lacomblez, C. Bonnet, D. Grabli, S. Klebe, G. Mangone, H. You, V. Mesnage, A. Brice, M. Vidailhet, J.-C. Corvol, A. Elbaz (Taipei, Taiwan)

    Objective: To examine whether brain reserve plays a role in the severity and progression of motor, cognitive, and non-motor symptoms in Parkinson’s disease (PD), by…
  • 2017 International Congress

    Validation of the Utility of Brief Smell Identification Test Simplified Chinese Version 2 in Chinese Parkinson’s disease

    M. Cao (Beijing, China)

    Objective: To validate the utility and efficiency of Brief Smell Identification Test Simplified Chinese Version 2 (B-SIT CV2) in Chinese Parkinson's disease patients and investigate…
  • 2017 International Congress

    Clinical Predictors of Dementia and Other Non-Motor Symptoms in Parkinson’s Disease

    D. Lichter, S. Finnegan (Buffalo, NY, USA)

    Objective: To clarify clinical predictors (pX) of dementia and other non-motor symptoms (NMS) in Parkinson's disease (PD). Background: The postural instability-gait disorder (PIGD) phenotype has…
  • 2017 International Congress

    Impulse control disorder and associated clinical factors in drug-naïve Parkinson’s disease.

    D. Gupta, M. Marano, S. Fahn (New York, NY, USA)

    Objective: To investigate various clinical factors associated with Impulse Control Disorders (ICD) in Parkinson's disease (PD) patients who have never been exposed to Dopamine Replacement…
  • 2017 International Congress

    Dream content in Parkinson’s Disease

    V. Malgrati, F. Mancini, L. Manfredi, M. Lacerenza, A. Maggiolini (Milan, Italy)

    Objective: The aim of this observational study is to perform an analysis of dream characteristics in a large sample of Parkinson's Disease (PD) patients and…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley